The AI Spending Dilemma: More Employees or More Tokens?

What if your next big corporate budget debate isn't about headcounts, but word counts? Welcome to the token economy. Every time an algorithm drafts an email or audits a contract, it chips away at your bottom line. Suddenly, monthly software bills are rising rapidly and, in some cases, approaching major labor costs, forcing CFOs to solve a bizar...

Preety Shaha

Author

Read Full Article

The AI Spending Dilemma: More Employees or More Tokens?

News Briefs

Faraday Future Reports Strong Growth in EAI Robot Sales and Delivery

EAI robots are gaining strong market traction as Faraday Future announced record sales and shipments in May. The company reported 69 units delivered, surpassing the combined total from March and...

Otarmeni Gains EMA Review for Genetic Hearing Loss

The European Medicines Agency accepted the marketing application for Otarmeni, a gene therapy targeting rare inherited hearing loss. The company received the filing acceptance under the agency’s...

Digital Turbine Deepens Google Cloud Alliance to Boost Mobile AI

Digital Turbine AI partnership took a major step forward as the company strengthened its work with Google Cloud. The move focuses on improving AI-powered mobile advertising and recommendations at glob...

Arcesium Launches AI Platform for Institutional Investing

Arcesium AI platform has entered the market with a focused push toward transforming institutional investment workflows. The company introduced Arcesium Intelligence, a purpose-built system designed fo...

Spectrum Rolls Out Ultra-Low Latency Broadband Network

Spectrum ultra-low latency internet has launched in select U.S. markets, offering faster and more responsive online experiences. The new Spectrum ultra-low latency internet service focuses on reducing...

US Supreme Court Rejects Pharma Challenge to Drug Prices

The US Supreme Court's decision to reject a key pharmaceutical challenge to Biden-era drug price reforms is a significant legal step for the healthcare and pharmaceutical industries. This enables ...

FDA Approves Atezolizumab for Targeted Bladder Care

The United States Food and Drug Administration announced that it approved atezolizumab for adjuvant treatment of muscle-invasive bladder cancer. This decision introduces atezolizumab as a precision im...

Europe Advances Genomic Surveillance of Antimicrobial Resistance

Europe made great progress in the battle against antibiotic resistance with the development of genomic surveillance across several countries. The recent multi-country initiative coordinated by the Eur...

Explore More